The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

2010/08/18 by Franz X. Vollenweider, Michael Kometer · 3 citations
Neuroscience · Psychology · #Neurotransmitter Receptor Influence on Behavior #Psychedelics and Drug Studies #Tryptophan and brain disorders

paper · doi:10.1038/nrn2884

crossref issued 2010/08/18 · crossref published 2010/08/18 · crossref published-online 2010/08/18 · openalex publication_date 2010/08/18 · crossref created 2010/08/18 · crossref published-print 2010/09/01 · crossref deposited 2025/02/24 · openalex created_date 2025/10/10 · crossref indexed 2026/08/03 · openalex updated_date 2026/08/04

Citations

• Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
• Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
• Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study
• A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
• Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
• Response of cluster headache to psilocybin and LSD
• A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis
• The Early Symptoms of Schizophrenia
• Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.
• Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms

Cited by

• Fluorine in psychedelic phenethylamines
• Psychedelics Promote Structural and Functional Neural Plasticity
• Psychedelics and ecology [wikipedia]